Grape phenolic extract potentially useful in the control of antibiotic resistant strains of Campylobacter by Mingo, Elisa et al.
Advances in Microbiology, 2014, 4, 73-80 
Published Online January 2014 (http://www.scirp.org/journal/aim) 
http://dx.doi.org/10.4236/aim.2014.42012  
Grape Phenolic Extract Potentially Useful in the Control of 
Antibiotic Resistant Strains of Campylobacter 
Elisa Mingo1, Alfonso V. Carrascosa1, Sonia de Pascual-Teresa2,  
Adolfo J. Martinez-Rodriguez1* 
1Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, Departamento de Biotecnología y Microbiología.  
C/Nicolás Cabrera, 9. Cantoblanco Campus, Universidad Autónoma de Madrid, Madrid, Spain 
2Instituto de Ciencia y Tecnología de Alimentos y Nutrición (ICTAN), CSIC, Departamento de Metabolismo  
y Nutrición-C/Jose Antonio Novais, Madrid, Spain 
Email: *adolfo.martinez@csic.es   
 
Received November 7, 2013; revised December 7, 2013; accepted December 14, 2013 
 
Copyright © 2014 Elisa Mingo et al. This is an open access article distributed under the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In accor-
dance of the Creative Commons Attribution License all Copyrights © 2014 are reserved for SCIRP and the owner of the intellectual 
property Elisa Mingo et al. All Copyright © 2014 are guarded by law and by SCIRP as a guardian. 
ABSTRACT 
In this work, a grape phenolic extract obtained by methanol extraction has been demonstrated to be effective in in- 
hibiting the growth of different strains and species of Campylobacter, one of the most important bacterial food- 
borne pathogens causing gastroenteritis worldwide. Noteworthily, it was particularly effective against several 
strains presenting multiple antibiotic resistances. In all cases, the minimum inhibitory concentration (MIC) was 
lower than 300 mg GAE/L, being of 60 mg GAE/L for one of the most resistant strains (C. coli LP2), while the 
others were between 120 mg GAE/L and 180 mg GAE/L. The analytical study of the main phenolic compounds 
in the grape extract revealed that it was mainly constituted by catechins (85.7%) and phenolic acids (13.7%). 
However, experiments developed using pure standards demonstrate that phenolic acids (such as gallic, p-hi- 
droxibenzoic, vanillic, and homovanillic acids) were the most active, provoking a Campylobacter growth decrease 
between 6.7 and 7.6 log, while epicatechin was the only catechin with activity as pure compound (1 log of growth 
decrease). 
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1. Introduction 
Campylobacter species are the leading causes of bacterial 
food-borne gastroenteritis worldwide and the species 
Campylobacter jejuni (C. jejuni) and Campylobacter coli 
(C. coli) cause more than 95% of the infections attributed 
to this genus [1]. Campylobacter infections in humans 
are usually characterized by self-limiting diarrhea, abdo- 
minal cramps, nausea and fever, but severe neurological 
sequelae, bacteremia, and other extraintestinal complica- 
tions may develop less frequently [2]. Several sources of 
Campylobacter infection in humans have been suggested, 
but the most common is mainly associated with the con-
sumption and/or handling of poultry meat, especially 
fresh broiler meat [3]. Although most infections are re- 
solved without specific treatment, antimicrobial therapy 
can be critical in invasive or severe infections. Fluoroqui- 
nolone agents, like ciprofloxacin and macrolides such as 
erythromycin, are commonly used for the treatment of in- 
fections caused by Campylobacter [4]. However, the rise 
in the incidence of infections caused by antibiotic-re- 
sistant strains of Campylobacter makes this illness in- 
creasingly difficult to treat [5]. Moreover, since a large 
proportion of the European Union (EU) chicken produc- 
tion is contaminated with the pathogen [6] and given the 
recent ban by the European Union on the use of antibio- 
tics in animal feed to promote growth [7], it is essential 
to search for new, natural and sustainable strategies to 
reduce the incidence of Campylobacter in the food chain, 
especially in its main host. Consumer concerns about the *Corresponding author. 
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safety of food have increased, and in this regard, there is 
a growing interest in the use of natural antibacterial com- 
pounds, like plant extracts rich in phenolic compounds, 
as food preservatives. In the last years, different works 
about the antimicrobial properties of wine and grape phe- 
nolic compounds have been published, and several stu- 
dies have shown that these compounds could inhibit the 
growth of different food-borne bacteria [8,9]. Concerning 
Campylobacter, other researchers have reported that 
some phenolic compounds from grape leaves can have an- 
timicrobial activity against this pathogen [10], contribut- 
ing to modulating the resistance to macrolide antibiotics 
[11]. We have previously reported the antimicrobial ac- 
tivity of a commercial extract of GSE against Campylo- 
bacter, identifying the main phenolic compounds related 
with the behavior observed [12]. In this work, we have 
obtained several grape extracts using two solvents (me- 
thanol and water). The most active extract has been se- 
lected to study its antibacterial activity against different 
species and strains of Campylobacter, identifying the main 
compounds responsible for the antibacterial activity. The 
bactericidal effect was compared to that of 10 different 
antibiotics, with the purpose of establishing the potential 
of grape phenolic compounds in the control of Campylo- 
bacter. 
2. Materials and Methods 
2.1. Bacterial Strains, Growth Media, and  
Culture Conditions 
The microorganisms used in this study included 12 dif- 
ferent strains: 9 of C. jejuni and 3 of C. coli. Strain spe- 
cification and origin of the specimen is provided in 
Table 1. 
 
Table 1. Source of Campylobacter species obtained from ve- 
terinary, clinical and collection libraries. La Paz and Carlos 
III are hospitals of Madrid, Spain. 
Specie Strain Origin Source 
Campylobacter  
jejuni 
 
 
 
 
 
 
 
LP1 
11168 
118 
11351 
CIII 
CN1 
CNL1 
CNL2 
7572 
Clinical 
Collection 
Clinical 
Collection 
Clinical 
Veterinary 
Veterinary 
Veterinary 
Collection 
La Paz 
NCTCa 
Carlos III 
NCTC 
Carlos III 
CIALb 
CIAL 
CIAL 
CECTc 
Campylobacter 
coli 
 
 
LP2 
CNL4 
7571 
Clinical 
Veterinary 
Collection 
La Paz 
CIAL 
CECT 
aBacterial cultures obtained from the National Collection of Types Cultures 
(NCTC), UK, bCollection from Instituto de Investigación en Ciencias de la 
Alimentación, (CIAL), cSpanish Collection of Type Cultures (CECT). 
All strains were stored at −80˚C. Liquid growth me- 
dium for Campylobacter strains consisted of Brucella 
Broth (BB) (Becton, Dickinson, & Company, New Jer- 
sey, USA). The agar plating medium consisted of Müel- 
ler-Hinton agar supplemented with 5% defibrinated sheep 
blood (MHB) (Becton, Dickinson, & Company). The fro- 
zen strains were reactivated by inoculation in MHB and 
incubation under microaerophilic conditions (85% N2, 
10% CO2, 5% O2) using a Variable Atmosphere Incuba-
tor (VAIN) (MACS-VA500) (Don Whitley Scientific, 
Shipley, UK) at 42˚C for 48 h. Isolated colonies were 
inoculated into 50 ml of BB and incubated under stirring 
at 130 rpm on an orbital shaker (Shaker S3) (Elmi, Riga, 
Latvia) at 42˚C for 24 h in microaerophilic conditions in 
the VAIN. These bacterial inocula cultures (~1 × 108 
CFU/ml) were used for the antibacterial activity assays. 
2.2. Antibiotic Susceptibility Testing 
The antibiotic susceptibility was assessed for each strain 
following the Kirby-Bauer disc diffusion method based 
on the performance standards for antimicrobial disk sus- 
ceptibility test [13]. The bacterial inoculum in BB was 
spread onto MHB using sterile cotton-tipped swabs. An- 
timicrobial discs (Oxoid, Basingstoke, UK) were placed 
on the inoculated MHB plates and they were incubated in 
the VAIN for 48 h. The following antimicrobial discs 
were used: aztreonam, tetracycline, gentamicin, cephalo- 
thin, amoxicillin-clavulanic acid, nalidixic acid, chloram- 
phenicol, erythromycin (all 30 µg), streptomycin (25 µg), 
and ciprofloxacin (5 µg). Interpretation of the results was 
performed using the resistance breakpoint for Campylo- 
bacters described by others [14,15]. When no breakpoints 
were available for Campylobacters, the resistance break- 
point described by CLSI for Enterobacteriaceae was used. 
The breakpoints are shown in Table 2. 
2.3. Grape Extracts Preparation 
Phenolic extracts were prepared from three varieties of 
Vitis vinifiera grapes: Tempranillo, Garnacha and Caber- 
net Sauvignon. Extraction and concentration of the phe- 
nolic fraction was carried out by the procedure describ- 
ed by Pallauf et al. [16]. Two different solvents were us- 
ed in the extraction process: methanol, as non-polar sol- 
vent, and water (polar solvent). 
Briefly, fresh grapes were homogenized using an Ul- 
tra-Turrax T25 (IKA-WERKE GmbH & Co., Staufen, 
Germany) for 2 - 3 min. to obtain 100 g of grape’s homo- 
genated. 100 ml of methanol 100% (Sigma-Aldrich, Mis- 
souri, USA) or water was added to the homogenate and 
mixed for 15 min. Afterwards, it was centrifuged for 10 
min. at 4500 rpm and the supernatant was collected. The 
extraction process was repeated twice more.  
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Table 2. Breakpoints for Campylobacter spp. 
Antibiotic Potency R I S 
Gentamicin** 10 µg ≤12 13 - 14 ≥15 
Cephalotin*** 30 µg ≤14 15 - 17 ≥18 
Streptomycin*** 10 µg ≤10 11 - 12 ≥15 
Tetracyclin** 30 µg ≤14 15 - 18 ≥19 
Cloramphenicol* 30 µg ≤11 12 - 22 ≥23 
Eritromycin* 15 µg ≤15 16 - 18 ≥19 
Aztreonam*** 30 µg ≤15 16 - 21 ≥22 
Nalidixic Acid** 30 µg ≤13 14 - 18 ≥19 
Ciprofloxacin* 20/10 µg ≤13 14 - 17 ≥18 
Amoxicillin  
Clavulanic Acid*** 5 µg ≤18 19 - 23 ≥24 
*Miflin et al. (2007), **Luangtongkum et al. (2007), ***Clinical Laboratory 
Standards Institute (CLSI) (2007). 
 
The extracts were then combined, filtered through a 
Büchner funnell and concentrated by evaporation at 30˚C 
(Rotavapor® 210 R-210 BÜCHI) (Labortechnik AG, Fla- 
wil, 211 Switzerland). The extract obtained in each case 
was suspended in 100 ml of water. The resulting aqueous 
extracts were then lyophilized and the powder stored at 
−20˚C. 
2.4. Antibacterial Activity of the Grape Extract 
A first screening was performed to analyze the antibac- 
terial activity of the different grape extracts (Tempranillo, 
Garnacha and Cabernet Sauvignon) against C.jejuni LP1. 
The extract which showed the strongest antibacterial ac- 
tivity was then selected for the following experiments 
with antibiotic-resistant strains. In all cases we used the 
following quantitative procedure: 1 ml of sample was 
transferred into different flasks containing 4 ml of BB. 
Bacterial inocula (50 µl with 1x108 colony forming units 
x mililiter (CFU/ml) were then inoculated into the flasks 
under aseptic conditions. All cultures were prepared in 
triplicate and incubated microaerobically at 42˚C for 24 h 
(130 rpm) in the VAIN. Positive growth controls were 
prepared by transferring 1 ml of saline solution (NaCl 
0.9%) to 4 ml of BB and 50 µl of bacterial inocula. After 
incubation, serial decimal dilutions of mixtures were 
prepared in saline solution and they were plated (10 µl) 
onto fresh MHB agar and incubated microaerobically at 
42˚C in the VAIN. The number of CFU was assessed 
after 48 h of incubation. Results were expressed as log 
CFU/ml. The minimal inhibitory concentration (MIC) 
and the minimal bactericidal concentration (MBC) were 
determined following the procedure described above and 
by using each grape extract diluted in sterile water to 
obtain the desired final concentration. MIC was defined 
as the lowest concentration of sample that provokes a 
statistically significant decrease in viability with respect 
to the control growth after 24 h of treatment. MBC was 
defined as the lowest concentration of sample where no 
growth was observed after 24 h of treatment. 
2.5. Assessment of Total Phenolic Content (TPC) 
The total phenolic content (TPC) in the different grape 
extracts was determined in accordance with the Folin- 
Ciocalteu micro method as previously described by Sch- 
midt et al. [17]. Briefly, samples (10 µl) were added to a 
96-well microtiter plate (Sarstedt, Nümbrecht, Germany) 
at an adequate dilution in triplicate. To start the reaction, 
150 µl of aqueous Folin-Ciocalteu (Sigma-Aldrich) solu- 
tion (14 ml water to 1 ml of Folin-Ciocalteu reagent) was 
added to each well. After 3 minutes, 50 µl of NaHCO3 
solution (2 ml of saturated NaHCO3 to 3 ml of water) 
was added to each well and the plate was placed in the 
dark at room temperature for 2 h. Absorbance was mea- 
sured at 725 nm using a BioTek Synergy HT Multi-Mode 
microplate reader (BioTek Instruments Inc., Vermont, 
USA), and the data were acquired and processed using 
BioTek’s Gen5TM software (BioTek Instruments Inc.). 
Gallic acid (Sigma-Aldrich) was used as the standard for 
a calibration curve. TPC was expressed as milligrams of 
gallic acid equivalents per liter (mg GAE/L). 
2.6. Determination of Individual Phenolic  
Compounds of the Extracts by HPLC and  
Mass Spectrometry Detection 
All HPLC analyses were carried out on a Hewlett-Pack- 
ard Agilent 1200 Series liquid chromatography system 
equipped with a quaternary pump and a photodiode array 
detector (DAD) (Agilent Technologies, Waldrom, Ger- 
many). The column used was a Phenomenex Luna C18 
column (4.6 × 150 mm, 5 μm) (Phenomenex, California, 
USA) which was set thermostatically at 25˚C. Chroma- 
tographic data were acquired and processed using an 
Agilent Chemstation for LC 3D system (Rev. B.04.01) 
(Agilent Technologies). The HPLC method conditions 
were as described by Avila et al. [18]. Briefly, the binary 
mobile phase used for analyses were aqueous 4.5% for- 
mic acid (A) and HPLC-grade acetonitrile (B) at a flow 
rate of 0.5 ml/min. The elution started with 10% B, and 
the gradient was 20% B from 0 to 20 min, 25% B from 
20 to 30 min, and 35% B from 30 to 50 min. Detection 
wavelengths were 280, 320, 440 and 520 nm and samples 
were analyzed in triplicate. Peaks were identified by 
comparing their retention time and UV-vis spectra with 
the reference compounds, and the data were quantified 
using the corresponding curves of the reference com- 
pounds as standards. In order to confirm the identity of 
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the recorded compounds, additional analyses were per- 
formed by using HPLC with mass spectrometry detection 
(HPLC-MS). For mass spectrometry an Agilent 1100 
series liquid chromatograph/mass-selective detector equip- 
ped with a quadrupole (G1946D) mass spectrometer 
(Agilent Technologies) was used. Separation was achiev- 
ed with an ORBAX Eclipse XDB-C18, (4.6 × 150 mm, 5 
µm) (Agilent Technologies). Elution was performed with 
a gradient between 2.5% acetic acid in Milli-Q water (so- 
lution A), a mixture of 2.5% acetic acid in Milli-Q and 
water-acetonitrile (90:10) (solution B), and pure acetoni- 
trile (solution C) at a flow rate of 0.5 ml/min, and an in- 
jection volume of 20 µl. The elution programme consist- 
ing of the following: from 100% A to 100% B in 3 min, 
from 100% to 93% B in 5 min, from 7% to 10% C in 7 
min, from 10% to 15% C in 5 min, from 15% to 50% C in 
5 min and isocratic 50% C and B for another 5 min. 
Electrospray ionisation in the positive mode was used. 
The electrospray capillary voltage was set to 2500 V, with 
a nebulising gas flow rate of 12 liters/min and a drying 
gas temperature of 150˚C. 
2.7. Antimicrobial Activity Assay of Pure  
Phenolic Compounds 
The phenolic compounds identified in the most active 
extract were tested against C. jejuni LP1 as pure com- 
pounds. The assayed compounds (quercetin, quercetin 3- 
glucoside, homovanillic acid, vanillic acid, gallic acid, 
protocatechuic acid, clorogenic acid, p-hidroxibenzoic 
acid, sinapic acid, catechin, epicatechin, and procyani- 
dins B1, B2 were purchased from Sigma-Aldrich). The 
procedure used has been described above. CFU was as- 
sessed after 48 h of incubation. Results were expressed 
as log CFU/ml. 
2.8. Statistical Analysis 
Analysis of variance (ANOVA) was performed by SPSS 
19.0 for Windows, version 19.0.0 (Dec. 2011). 
3. Results and Discussion 
3.1. Antibiotic Susceptibility Test for  
Campylobacter spp. 
The results of the antibiotic susceptibility test are shown 
in Table 3. The sensitivity to antibiotics was dependent 
on the Campylobacter strain. Strains from international 
culture collections (11168, 11351, 7572 and 7571) were 
the most sensitive, presenting from null to 2 antibiotic 
resistances. On the other hand, recent isolates from clin- 
ical (LP2) and veterinary origin (CN1 and CNL4) were 
resistant to five antibiotics. Among antibiotics, the high 
percentage of resistances were found in ciprofloxacin 
(66.6%) and nalidixic acid (58.3%), both of them of the  
fluoroquinolones group, whereas all strains tested were 
sensitive to aminoglucosides (streptomycin and gentami- 
cin), chloramphenicol and amoxicillin/clavulanic acid. It 
is known that bacteria often lose virulence by growth in 
vitro, and that the genetics basis for virulence may be 
expressed completely only during growth in vivo. This 
fact has been observed for Campylobacters, where the 
comparation of the transcriptional profile of the original 
clonal isolate of C. jejuni 11168 and the genome-se- 
quenced clone of C. jejuni 11168 showed important dif- 
ferences in gene expression [19]. Also, the use of re- 
peatedly subcultured strains of Helicobacter pylori (H. 
pylori), a close-related microorganism, in virulence ex- 
periments, has shown the loss of several virulence prop- 
erties respect to the original strain [20]. These results 
demonstrate the effect of laboratory culture and storage 
on virulence properties, suggesting the importance to use 
strains with low subcultures in studies of virulence and/ 
or sensitivity to drugs. The behavior against fluoroquino- 
lones has confirmed the striking increase in resistance of 
Campylobacter against these drugs in the last years, ren- 
dering now in a limited use of them in the treatment of 
campilobacteriosis in many regions [2]. Only C. coli (LP2) 
was resistant to erythromycin, one of the first choices in 
the antibiotic treatment of campilobacteriosis due to its 
low resistance rates (0% to 12%), although it is generally 
higher in C. coli, ranging from 0% to 50% [21]. Even if 
the majority of C. jejuni and C. coli are resistant to β- 
lactam agents, amoxicillin plus clavulanic acid has al- 
ready been reported as effective [22], in accordance with 
the results obtained in the present work. Other drugs such 
as tetracycline and chloramphenicol can be alternative 
antibiotics, but up to 60% of strains may be resistant to 
tetracycline [23]. 
In the last years, it has been found that some com- 
pounds derived from plants can be active against antibi- 
otic-resistant pathogens associated with foods, possibly 
by using different mechanisms of action [24]. For this 
reason, in the present work we evaluate the effect of 
three different grape extracts against Campylobacter in 
order to clarify its possible use as an antimicrobial. 
3.2. Antibacterial Effect of Grape Extracts on  
Campylobacter spp. 
The results of the antibacterial activity of the different 
grape extracts against C. jejuni LP1 showed that phenolic 
extraction using methanol as solvent (average 4.56 log of 
growth inhibition) was more effective than the extrac- 
tion with water (average 1.91 log of growth inhibition) 
(Table 4). This is consistent with the total phenolic con- 
tent (TPC) determined for each extract, which showed 
that the amount of phenolic compounds extracted using 
methanol was higher than the one obtained with water     
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Table 3. Antimicrobial susceptibility profile for the Campylobacter spp. strains by Kirby-Bauer disc diffusion method. 
Antibiotic LP1 1168 118 11351 CIII CN1 CNL1 CNL2 7571 LP2 CNL4 7572 
Gentamicin S S S S S S S S S S S S 
Cephalotin S R R R R R R R S R R R 
Streptomycin S S S S S S S S S S S S 
Tetracyclin I S S S I R R R S I R S 
Chloramphenicol S S S S S S S S S S S S 
Eritromycin S S S S S S S S S R S S 
Aztreonam S S S R R R S S S R R R 
Nalidixic Acid R S R S S R R R S R R S 
Ciprofloxacin R S R S R R R R S R R S 
Amoxicillin-Clavulanic Acid S S S S S S S S S S S S 
S: susceptible; R: resistant; I: intermediate. 
 
Table 4. Antibacterial activity of three different grape extracts against C. jejuni LP1. Three varieties of grapes (Cabernet 
Sauvignon, Garnacha and Tempranillo) were tested, and two different extractions were obtained (methanolic or water) for 
each grape variety. The results are expressed in Log CFU/ml ± standard deviation (SD) (n = 3). 
 TPC 
(mg GAE/L) 
Median log CFU/ml ± SD (log reduction) (n = 3) 
Strain Grape extract Control Extract Log Inhibition 
C. jejuni 
LP1 
Cabernet S. (M) 224.67 8.49 ± 0.1 4.78 ± 1.1a 3.71 
Cabernet S. (W) 103.53 8.2 ± 0.1 5.14 ± 0.8a 3.06 
Garnacha (M) 218.43 8.7 ± 0.1 3.92 ± 0.9a 4.78 
Garnacha (W) 103.53 8.24 ± 0.2 8.28 ± 0.6 0.00 
Tempranillo (M) 224.09 8.5 ± 0.1 3.32 ± 0.7a 5.18 
Tempranillo (W) 126.31 8.2 ± 0.1 6.67 ± 1.0a 2.13 
Cabernet S. (M) 224.67 8.49 ± 0.1 4.78 ± 1.1a 3.71 
 
coinciding with the reported by others [25]. However, no 
differences were observed in the individual phenolic 
compounds extracted, which were the same indepen- 
dently of the extraction method used (data not shown). 
Among the methanolic extracts, the most effective was 
the Tempranillo extract. Thus, we selected it for next 
series of experiments. 
The results of the antibacterial activity of the selected 
grape extract against different Campylobacter strains are 
presented in Table 5. For this assay, the five most resis- 
tant strains (with 4 or 5 antibiotic resistances) were used 
and the clinical isolate LP1 (with 2 antibiotic resistances) 
was also included. With the purpose to determine the 
lower concentration of the grape extract able to inhibit 
Campylobacter growth we calculated the MIC and MBC 
for each strain. The results obtained showed a relation- 
ship between strain and sensitivity. In all cases, the MIC 
was lower than 300 mg GAE/L, being the lowest value of  
60 mg GAE/L for C. jejuni LP1 (two antibiotic resis- 
tances) and C. coli LP2 (five antibiotic resistances). The 
MIC for the other strains was 120 mg GAE/L (C. jejuni 
CN1, CNL1, and CNL2) and 180 mg GAE/L for C. coli 
CNL4. The MBC was between 240 mg GAE/L and 120 
mg GAE/L, showing a similar behavior as MIC. In gen- 
eral terms the extract showed a strong capacity to inhibit 
Campylobacter growth regardless of the Campylobacter 
species (C. jejuni or C. coli) or the origin of the strain 
(human or veterinary). These MIC and MBC values seem 
relevant, taking into account that they are below 100 
mg/L [26]. 
3.3. Phenolic Composition of the Grape Extract 
In Table 6 are shown the main individual phenolic com- 
pounds identified in the Tempranillo grape extract. The 
main group of phenolic compounds in the extract consist- 
ed of catechins (85.7%) and phenolic acids (13.7%).  
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Table 5. MIC and MBC of the Tempranillo grape extract against different antibiotic resistant strains of Campylobacter spp. 
The results are expressed in Log UFC/ml ± standard deviation (SD) (n = 2). 
Median log CFU/ml ± SD (log reduction) (n = 2) 
Concentration of the grape  
phenolic extract (mg GAE/L) Campylobacter strain 
 C. jejuni LP1 C. jejuni CNL1 C. jejuni CN1 C. jejuni CNL2 C. coli LP2 C. coli CNL4 
Control 7.89 ± 0.2 8.04 ± 0.2 8.45 ± 0.2 8.39 ± 0.1 7.54 ± 0.2 8.01 ± 0.2 
300 >1.48a* ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0 
240 >1.48a ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0 >1.48a ± 0.0*** >1.48a ± 0.0 >1.48a ± 0.0** 
180 >1.48a ± 0.0 >1.48a ± 0.0*** >1.48a ± 0.0*** 4.90a ± 1.4 >1.48a ± 0.0 4.60a ± 0.2** 
120 >1.48a ± 0.0*** 5.38a ± 0.0** 6.45a ± 0.7** 6.75a ± 0.1** >1.48a ± 0.0*** 7.70 ± 0.1 
60 2.77a ± 1.2** 8.40 ± 0.8 8.40 ± 0.1 8.49 ± 0.7 7.13a ± 1.0** 7.95 ± 0.2 
30 8.58 ± 0.2 8.77 ± 0.2 8.70 ± 0.0 8.29 ± 1.1 8.65 ± 0.2 8.17 ± 0.0 
*Calculated log of detection limit (30 CFU per plate). **Minimal Inhibitory Concentration (MIC), ***Minimal Bactericidal Concentration (MBC), a significantly 
different with respect to the growth control (p ≤ 0.05). 
 
Table 6. Individual phenolic composition (mg/L) of the Tem- 
pranillo grape extract (mean ± standard deviation) (n = 3) 
determined by HPLC-MS. 
Family Compound Concentration (mg/L) 
Flavonols Quercetin-3-glucoside 4 ± 0.0 
 Quercetin 7 ± 0.0 
Phenolic Acids Gallic Acid 37 ± 0.1 
 Homogentisic Acid 21 ± 0.0 
 Protocatechuic Acid 27 ± 7.0 
 Chlorogenic Acid 6 ± 0.1 
 Homovanillic Acid 72 ± 4.6 
 Vanillic Acid 41 ± 2.0 
 p-cumaric Acid 12 ± 0.0 
 p-Hidroxibenzoic Acid 21 ± 1.6 
 Sinapic Acid 31 ± 1.0 
Catechins Catechin (cat) 680 ± 4.4 
 Epicatechin (ec) 806 ± 8.1 
 B1 (cat-ec) 66 ± 1.3 
 B2 (ec-ec) 130 ± 23.1 
TOTAL  300* ± 0.0 
*Total phenolic content (mg GAE/L). 
 
Epicatechin and catechin were the major identified com- 
pounds, while homovanillic, vanillic and gallic acid were 
the most abundant within phenolic acids. The total phe- 
nolic compounds in the grape extract were quantified in 
300 mg GAE/L. Vanillic and gallic acid moieties have  
been associated before with a loss of cytoplasmic mem- 
brane integrity, with the resultant loss of ion gradients, 
pH homeostasis and inhibition of respiratory activity [27]. 
On the other hand, the mechanisms of action proposed 
for the antibacterial activity of catechins have been main- 
ly attributed to cytoplasmic membrane damage, although 
other mechanisms could be involved [28]. 
With the purpose to evaluate the impact of the phenol- 
ic compounds presented in the extract in the observed 
behavior, the pure phenolic compounds identified as part 
of the most active extract (homovanillic acid, vanillic 
acid, gallic acid, protocatechuic acid, clorogenic acid, p- 
hidroxibenzoic acid, catechin, epicatechin, and procya- 
nidin dimmers B1 and B2) were tested against C. jejuni 
LP1 and results are shown in Table 7. Phenolics acids 
were the most active of the assayed compounds, provok- 
ing a growth decrease between 6.7 and 7.6 log, while epi- 
catechin was the only flavanol with activity as pure com- 
pound (1 log). These results show the contribution of phe- 
nolic acids to the inhibition of Campylobacter growth, al- 
though as part of the extract, additive and/or synergistic 
effects could be involved in the behavior observed in the 
case of the grape extract. This fact was previously de- 
scribed by us for the GSE extract [12] and others are ob- 
served a similar behavior for some catechins [28] and for 
phenolic acids such as gallic acid [29]. 
4. Conclusion 
In summary, the results obtained in this work indicate 
that grape extracts could be an important source of phe- 
nolic compounds potentially active against Campylo- 
bacter. The grape extract assayed has been demonstrated 
to be useful against Campylobacter strains with multiple an- 
tibiotic resistances. Phenolic acids have been identified as  
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Table 7. Effect of the standard phenolic compounds on the 
growth of C jejuni LP1. All the compounds were tested at 1 
mg/ml, except B1 and B2, which activity was assayed at 0.5 
mg/ml. The results are expressed in Log UFC/mL ± stan- 
dard deviation (SD) (n = 2). 
Median log CFU/ml ± SD (log reduction) (n = 2) 
Family Compound Control Compound Activity 
Log of 
Inhibition 
Flavonols Quercetin-3 -glucoside 8.28 ± 0.0 8.28 ± 0.0 NI
** 
 Quercetin 8.28 ± 0.0 8.28 ± 0.0 NI 
Phenolic 
Acids 
Homovanillic  
Acid 8.36 ± 0.1 >1.48a
* ± 0.0 6.88 
 Vanillic Acid 9.10 ± 0.1 >1.48a ± 0.0 7.62 
 Gallic Acid 8.15 ± 0.0 >1.48a ± 0.0 6.70 
 Protocatechuic Acid 8.78 ± 0.0 8.77a ± 0.1 NI 
 Chlorogenic Acid 8.20 ± 0.1 8.17a ± 0.1 NI 
 p-hidroxibenzoic Acid 8.15 ± 0.1 >1.48a ± 0.0 6.67 
 Sinapic Acid 8.40 ± 0.0 8.42 ± 0.2 NI 
Catechins Catechin (cat) 8.31 ± 0.1 8.84 ± 0.1 NI 
 Epicatechin (ec) 8.31 ± 0.1 7.27a ± 0.0 1.04 
 B1 (cat-ec) 8.21 ± 0.1 8.61 ± 0.1 NI 
 B2 (ec-ec) 8.21 ± 0.1 8.20 ± 0.1 NI 
*Calculated log of detection limit (30 CFU per plate). **NI: no growth inhi- 
bition. a Significantly different with respect to the growth control (p ≤ 0.05). 
 
the main compounds related with the behavior observed, 
and they are usually the main phenolics in grape and 
grape-derived products [30], constituting an important 
metabolite derived from the metabolism of more complex 
phenolic compounds, such as anthocyanins [31]. This fact 
could contribute to standardizing the production process 
of grape extracts to inhibit Campylobacter growth. 
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